Effect of long-term using of hormonal contraception on anti-Müllerian hormone secretion
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00669806%3A_____%2F16%3A10323384" target="_blank" >RIV/00669806:_____/16:10323384 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216208:11140/16:10323384
Výsledek na webu
<a href="http://www.tandfonline.com/doi/pdf/10.3109/09513590.2015.1121981" target="_blank" >http://www.tandfonline.com/doi/pdf/10.3109/09513590.2015.1121981</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3109/09513590.2015.1121981" target="_blank" >10.3109/09513590.2015.1121981</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Effect of long-term using of hormonal contraception on anti-Müllerian hormone secretion
Popis výsledku v původním jazyce
Anti-Mullerian hormone (AMH) is an important factor associated with female fertility and the ovarian reserve. There are several past studies available concerning the influence of hormonal contraception (HC) on serum AMH levels. Recent studies have reported that AMH levels in women using HC can be about 30% lower compared to those not using HC. However, earlier studies showed no reduction in AMH levels in HC users. We decided to evaluate the effects of long-term HC use (mean duration of HC use: 11.4 years) on AMH levels in women. To exclude potential shorter and reversible decreasing effects of HC on fertility function, we decided to include women in the study who had stopped using HC 1 year before the AMH sample collection. We examined 105 women who used HC and 44 women who had never used HC. The median concentration of AMH in the group of long-term users of HC was 2.89 and 3.37 ng/ml in the group of women who had never used HC. We found no statistically significant difference (p = 0.3261). In conclusion, we observed no negative impact of HC on the AMH serum levels. AMH can be used as an ovarian reserve marker for these women.
Název v anglickém jazyce
Effect of long-term using of hormonal contraception on anti-Müllerian hormone secretion
Popis výsledku anglicky
Anti-Mullerian hormone (AMH) is an important factor associated with female fertility and the ovarian reserve. There are several past studies available concerning the influence of hormonal contraception (HC) on serum AMH levels. Recent studies have reported that AMH levels in women using HC can be about 30% lower compared to those not using HC. However, earlier studies showed no reduction in AMH levels in HC users. We decided to evaluate the effects of long-term HC use (mean duration of HC use: 11.4 years) on AMH levels in women. To exclude potential shorter and reversible decreasing effects of HC on fertility function, we decided to include women in the study who had stopped using HC 1 year before the AMH sample collection. We examined 105 women who used HC and 44 women who had never used HC. The median concentration of AMH in the group of long-term users of HC was 2.89 and 3.37 ng/ml in the group of women who had never used HC. We found no statistically significant difference (p = 0.3261). In conclusion, we observed no negative impact of HC on the AMH serum levels. AMH can be used as an ovarian reserve marker for these women.
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FB - Endokrinologie, diabetologie, metabolismus, výživa
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2016
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Gynecological Endocrinology
ISSN
0951-3590
e-ISSN
—
Svazek periodika
32
Číslo periodika v rámci svazku
5
Stát vydavatele periodika
GB - Spojené království Velké Británie a Severního Irska
Počet stran výsledku
3
Strana od-do
383-385
Kód UT WoS článku
000373897000009
EID výsledku v databázi Scopus
2-s2.0-84949559930